Tags

Type your tag names separated by a space and hit enter

Topical brimonidine tartrate 0·33% gel effectively reduces the post-treatment erythema of daylight-activated photodynamic therapy.
Br J Dermatol. 2016 Jun; 174(6):1422-3.BJ

Links

Publisher Full Text (DOI)

Authors+Show Affiliations

Gerber PA
Department of Dermatology, Heinrich Heine University, Moorenstraβe 5, 40225, Düsseldorf, Germany. peterarne.gerber@med.uni-duesseldorf.de.

MeSH

Administration, CutaneousAdrenergic alpha-2 Receptor AgonistsAdultBrimonidine TartrateDrug EruptionsErythemaFacial DermatosesGelsHumansMalePhotochemotherapyRosaceaSunlight

Pub Type(s)

Case Reports
Letter

Language

eng

PubMed ID

26727630

Citation

Gerber, P A.. "Topical Brimonidine Tartrate 0·33% Gel Effectively Reduces the Post-treatment Erythema of Daylight-activated Photodynamic Therapy." The British Journal of Dermatology, vol. 174, no. 6, 2016, pp. 1422-3.
Gerber PA. Topical brimonidine tartrate 0·33% gel effectively reduces the post-treatment erythema of daylight-activated photodynamic therapy. Br J Dermatol. 2016;174(6):1422-3.
Gerber, P. A. (2016). Topical brimonidine tartrate 0·33% gel effectively reduces the post-treatment erythema of daylight-activated photodynamic therapy. The British Journal of Dermatology, 174(6), 1422-3. https://doi.org/10.1111/bjd.14384
Gerber PA. Topical Brimonidine Tartrate 0·33% Gel Effectively Reduces the Post-treatment Erythema of Daylight-activated Photodynamic Therapy. Br J Dermatol. 2016;174(6):1422-3. PubMed PMID: 26727630.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Topical brimonidine tartrate 0·33% gel effectively reduces the post-treatment erythema of daylight-activated photodynamic therapy. A1 - Gerber,P A, Y1 - 2016/03/31/ PY - 2016/1/5/entrez PY - 2016/1/5/pubmed PY - 2017/6/14/medline SP - 1422 EP - 3 JF - The British journal of dermatology JO - Br J Dermatol VL - 174 IS - 6 SN - 1365-2133 UR - https://www.unboundmedicine.com/medline/citation/26727630/Topical_brimonidine_tartrate_0·33_gel_effectively_reduces_the_post_treatment_erythema_of_daylight_activated_photodynamic_therapy_ DB - PRIME DP - Unbound Medicine ER -